General Health Care Authority rulemaking
This page includes all of the current rule making activity for General Health Care Authority.
Prescription drug affordability board - Data and confidentiality
Affected WACs
182-52-0050,
182-52-0095
Description
The agency is amending this rule to add language about data sharing between the prescription drug affordability board and the health care cost transparency board to align with Engrossed Substitute House Bill 1508, Chapter 80, Laws of 2024, Sec. 2, (2)(a). Additionally, the agency may add a new section regarding a time frame of 30 days for public comment prior to the board setting an upper payment limit to align with Substitute House Bill 1105, Chapter 171, Laws of 2024, Sec. 1, (1).
Agency contacts
Rulemaking contact
Valerie Freudenstein
Program contact
Mike Neuenschwander
Rulemaking status history
Preproposal (CR101)
- WSR 24-14-076
- Filed: 6/28/2024
Proposal (CR102)
- WSR 24-20-117
- Hearing Date: 11/5/2024
- Comments due by 11/5/2024
Permanent Adoption (CR103P)
- WSR 24-23-011
- Effective: 12/9/2024
Prescription Drug Program - Period of Appointment
Affected WACs
182-50-030
Description
The agency is amending WAC 182-50-030 to permit members of the pharmacy and therapeutics committee to serve for up to three consecutive three-year terms.
Agency contacts
Rulemaking contact
Brian Jensen
Program contact
Leta Evaskus
Rulemaking status history
Preproposal (CR101)
- WSR 24-10-017
- Filed: 4/19/2024
Proposal (CR102)
- WSR 24-13-041
- Hearing Date 7/25/2024
- Comments due by: 7/25/2024
Permanent Adoption (CR103P)
- WSR 24-16-022
- Effective: 8/26/2024
Prescription Drug Affordability Board
Affected WACs
182-52-0005,
182-52-0010,
182-52-0015,
182-52-0020,
182-52-0025,
182-52-0030,
182-52-0035,
182-52-0035,
182-52-0040,
182-52-0045,
182-52-0050,
182-52-0055,
182-52-0060,
182-52-0065,
182-52-0070,
182-52-0075,
182-52-0080,
182-52-0085,
182-52-0090
Description
To implement the Prescription Drug Affordability Board as required in SSSB 5532, Chapter 153, Laws of 2022.
Agency contacts
Rulemaking contact
Valerie Freudenstein
Program contact
Mike Neuenschwander
Rulemaking status history
Preproposal (CR101)
- WSR 22-15-035
- Filed: 7/14/2022
Proposal (CR102)
- WSR 23-21-082
- Hearing Date and Comments due by: 11/21/2023
- Registration required: https://us02web.zoom.us/webinar/register/WN_F8flPPyoSyqDs-EZHwgrLQ
Permanent Adoption (CR103P)
- WSR 24-02-078
- Effective: 6/10/2024
Drug price transparency - Data Confidentiality
Affected WACs
182-51-0900
Description
The agency is amending this rule to add language about data sharing between the Drug Price Transparency Program, the Prescription Drug Affordability Board, and the Health Care Cost Transparency Board to align with Engrossed Substitute House Bill 1508, Chapter 80, Laws of 2024, Sec. 2 (2)(a).
Agency contacts
Rulemaking contact
Melinda Froud
Program contact
Julie Colacurcio
Rulemaking status history
Preproposal (CR101)
- WSR 24-16-124
- Filed 8/6/2024
Proposal (CR102)
- WSR 24-24-052
- Hearing Date: 1/7/2025
- Register to attend the public hearing: Registration is required
- Comments due by 1/7/2025